{
  "folder": "IC-127",
  "content": "{{knowledge objective\n|Identifiant=OIC-127-01-A\n|Item_parent=Benign prostatic hypertrophy\n|Item_parent_short=Benign prostatic hypertrophy\n|Rank=A\n|Title=Knowing the clinical definition and natural history of benign prostatic hyperplasia (BPH)\n|Description=None\n|Topic=Definition\n|Contributors=Alexandre Ingels , Jonathan Olivier\n|Order=1}}\n \n\nBenign prostatic hyperplasia (BPH) corresponds to stromal (fibro-muscular) and epithelial (glandular) hyperplasia of the transitional and periurethral zone of the prostate. The term benign prostatic hyperplasia is used to describe clinical [[Urinary incontinence and voiding disorders in adults and the elderly|lower urinary tract symptoms 125]] symptoms that can be clinically and paraclinically linked to benign prostatic hyperplasia.\n\nNatural history of benign prostatic hyperplasia: BPH is common (80% of men over the age of 60). BPH develops continuously from the age of 30 onwards. BPH may remain asymptomatic, manifest itself through symptoms of the lower urinary tract (storage and emptying symptoms), or through acute and/or chronic complications.",
  "question": {
    "question": "What is the primary clinical manifestation of benign prostatic hyperplasia (BPH)?",
    "option_a": "Asymptomatic condition that does not affect urinary function",
    "option_b": "Symptoms related to the upper urinary tract",
    "option_c": "Lower urinary tract symptoms (LUTS) such as storage and emptying symptoms",
    "option_d": "Chronic pain in the lower abdomen",
    "correct_option": "C"
  }
}